Pulmonary artery catheters �PAC� allow measurement of hemodynamic vari� ables that cannot be measured reliably or continuously by less invasive means. Inherent to every medical intervention are risks associated with that intervention. This review categorizes complications associated with the PACi nto four broad groups -c omplica� tions of central venous access; complications related to PACinsertion and manipulation; complications associated with short� or long�term presence of the PACinthe cardiovas� cular system; and errors resulting from incorrect interpretation/use of PAC�derived data. We will discuss each of these four broad categories, followed by in�depth descriptions of the most common and most serious individual complications.
rameters arec entral to this goal. Pulmonary artery catheters (PAC) allow measurement of hemodynamic variables that cannot be assessed reliably or continuously by less invasive means (1) (2) . When used appropriately,the PACmay help characterize intravascular volume status, classify shock syndromes in hypotensive patients, and provide real-time evaluation of responses to therapeutic maneuvers aimed at correcting the shock state and optimization of tissue oxygen delivery.
Inherent to every medical intervention arer isks associated with that intervention. In addition to risks associated with invasive percutaneous vascular pro-
INTRODUCTION
Carefor the critically ill patient requires maintenance of adequate tissue perfusion and oxygenation. Rapid assessment and interpretation of hemodynamic pa-cedures, the PACentails risks associated with consequences of incorrect interpretation and/or misuse of PAC-derived hemodynamic data. We present acomprehensive review of PAC-associated complications.
BRIEF HISTORYOFTHE PULMONARYARTERY CATHETER
Reports of cardiac catheterization date to early 1900's (3) . Pulmonary artery catheterizations weres ubsequently performed in the 1940's to determine surgical risks of patients with congenital cardiac abnormalities and those with valvular disease (3) (4) . In 1953, a balloon-tipped catheter was developed (4) . Early PACs werer igid and their insertion was associated with bleeding and arrhythmias. It was not until the 1970's that PACs became popular (5) . Early PACs combined "floating" of the balloon-tipped catheter along the current of intracardiac blood flow with the use of thermodilution to estimate cardiac output (CO). Following development of flexible catheters, therewas an increase in ICU PACinsertions. In addition to measurement of CO, "wedging" the balloon tip in the pulmonary artery allows estimation of left heart filling pressures. Recent advances in PACtech-nology include ability to infuse intravenous medications, continuous measurement of CO, mixed venous oxygen saturation( SvO 2 ), and estimations of ventricular stroke volumes, among other parameters. Some catheter designs allow temporary transvenous cardiac pacing via the distal catheter port. Detailed list of indications and contraindications for PACuse can be found in Table 1 .
OVERVIEW OF COMPLICATIONS ASSOCIATED WITH PULMONARYARTERYCATHETERS
Significant numbers of patients who undergo pulmonary artery (PA) catheterization experience aP ACrelated complication (6) . Our goal should be to minimize the risk of these complications to ensurepatient safety.T his review divides complications associated with PACs into four broad groups: (a) complications of central venous puncture;(b) complications related to PA Ci nsertion and manipulation;( c) complications associated with short-or long-term presence of the PA Cin thecardiovascular system;and (d) those resulting from incorrecti nterpretation/use of PA C-derived data.T hese complication groups areb roadly discussed in the subsequent four sections, followed by in-depth sections on selected complications.
COMPLICATIONS OF CENTRAL VENOUS PUNCTURE
Complications of CV access include arterial puncture, arterial or venous hematoma, arteriovenous fistula (AVF), pseudoaneurysm formation, thoracic duct injury,pneumothorax/hemothorax, thrombosis and air embolization (7) (8) (9) . Inadvertent arterial puncture(in-cidence~1.9%) is usually managed by direct external compression of the artery and serious sequelae are uncommon ( Fig. 1) (25) . If arterial placement is not recognized immediately upon the initial puncture and ad ilating device is applied, prompt surgical or endovascular consultation and/or intervention should be obtained (10) . The thoracic duct may be injured during attempts to cannulate the left internal jugular or subclavian vein, potentially resulting in chylothorax or lymphatic cutaneous fistula. Attempted venous cannulation can cause pneumothorax in~0.5% of CV catheter placement cases (8) . Lifethreatening pneumothorax can result, especially in mechanically ventilated patients who may develop tension physiology.Limiting the number of CV access attempts and ultrasound guidance have been suggested to reduce these complications. Thrombosis is common following CV access, and results from disruption of endothelium, interruption of laminar blood flow by local vascular trauma, and indwelling catheter presence. Catheter-related thrombosis can occur with any typeofCVcatheter and rates varybyinsertion site. Subclavian venous catheterization carries the lowest thrombotic risk (1.9%), followed by internal jugular (7.6%) and femoral catheter placement (22%) (11) (12) (13) . Air embolism can result from negative intrathoracic pressuregenerated by aspontaneously Placement, manipulation, and prolonged indwelling of the PACcan be associated with significant complications. The incidence of complications may be in-The incidence of complications may be in-The incidence of complications may be inversely related to operator experience (11) (12) . Common complications associated with PACi nsertion include arrhythmias, pulmonary infarction, catheter knotting, catheter entanglement with other endovascular structures (i.e., vena cava filter), and PA rupture (6) (7) (8) (9) .
Cardiac arrhythmias. Cardiac arrhythmias occurring during PACi nsertion areu sually transient. Various types of arrhythmias related to PACplacement have been described and include ectopic atrial beats, atrial and ventricular tachycardias, ventricular ectopy,and conduction abnormalities (15) (16) .T he incidenceo f arrhythmia has been reported to range from 12.5% to over 70% during PACi nsertion (16) (17) (18) . Some cite a 52%-68% incidence of prematureventricular contractions (PVC), the most commonly seen arrhythmia (8, (15) (16) .N on-sustained ventricular tachycardias (VT) area lso common (8) . These resolve either with PACa dvancement from the RV into the PA,o rw ith prompt PACwithdrawal into the RA/superior vena cava (SVC). Fortunately,c linically significant VT or ventricular fibrillation requiring treatment occurs in <1%o fp atients, although fatal VT has been observed (8) .
Risk factors for ventricular arrhythmias during PACinsertion include prolonged catheterization time (17, 19) , predisposition for ventricular ectopy,l iver transplantation (incidence~37%) (19) , complicated myocardial infarction, significant acidemia, and sepsis (20) . Risk factors for ventricular arrhythmia during PACremoval include low CO and postoperatively increased CK-MB enzyme levels (21) . Most patients with VT have had recent myocardial infarction (18) . Trendelenburgp osition has been associated with higher incidence of clinically significant dysrhythmias than the right tilt position (22) . It has been suggested that arrhythmias occur moref requently during PACi nsertion as opposed to PACr emoval (21) , but this remains controversial (16) .
Transient right bundle branch block (BBB) after catheter positioning in the PA (incidence~5%) is usually not hemodynamically significant. However,com-However,complete heart block can occur during PACplacement in patients with left BBB, andm ay necessitate cardiac pacing (8, 23) . It is important to remember that left BBB should be considered acontraindication to PAC placement.
Approximately 3% of patients undergoing PAC placement requirea ntiarrhythmic therapy.U se of lidocaine prophylaxis beforeand during insertion of the PACd emonstrated no reduction of arrhythmias in one study,but therewas apotential risk reduction in the lidocaine group with catheterization time <20 minutes (24) .
Mechanical complications. Mechanical damage to cardiac structures (i.e., valves, chordae) can occur during PACplacement/manipulation but is uncommon (~0.9%) (25) (26) (27) (28) (29) . Catheters can also "knot" in the RV (Fig. 2 ). Mechanical complications appear to be associated with difficult catheter placement, particu-larly in the presence of enlarged RV (44) . Catheter entanglement can occur,a nd increased use of IVC filters, indwelling catheters, and pacemakers has led to increased occurrence of these complications (9, 26) . It may be possible to reduce the incidence of mechanical complications by limiting the intravascular PACinsertion depth to <60cmorbyuse of fluoroscopy.P Arupture/perforation is very rare, and is usually heralded by new onset hemoptysis (7) (8) .
Thrombosis and venous embolism. Electron microscopy studies of PAC-related thrombosis noted platelet aggregation/thrombus formation on catheters within 24 hours of insertion, with mored rastic increases by 72 hours. Pro-thrombotic endothelial dam-Pro-thrombotic endothelial damage also occurs with PACb alloon inflation and balloon cracking (27) . In one autopsy,o ver 60% of patients hadm ural thrombosisi nt he superior vena cava, the right atrium, or the PA (28) .
Infections. Catheter site infection, bacteremia/sepsis, and right-sided infective endocarditis arew ell described complications in patients with indwelling venous catheters and devices, including the PAC (6) (7) (8) . In large studies, PAC-associated bloodstream infection and bacteremia is 1.3%-2.3% (30) (31) . The PACitself can injureendocardial surfaces of tricuspid or pulmonary valves, which may contribute to rightsidedendocarditis (31) . Valvularvegetations and endocarditis can occur as frequently as 2.2%-7.1% (31), and patients with prosthetic valves areateven greater risk of PAC-associated endocarditis (8) . Maintenance ofstrict sterile conditions and the use of appropriate barrier precautions during PACp lacement may reduce the risk of PAC-associated infection. Because of infectious risk, it is important to remember that any PA catheter that was completely removed/withdrawn after discontinuing the initial sterile placement environment, should be discarded and anew PA catheter placed afterre-establishing sterile conditions.
MISINTERPRETATION/MISUSE OF PAC-DERIVED DATA
Errors in interpreting PACdata can lead to inappropriate therapy.C onsequently,s ome have suggested that the use of the PACm ight negatively contribute to patient care ( 1, 51) . Understanding the pitfalls of PACd ata acquisition/interpretation is essential to minimize risk of harm.
Errors of equipment and data acquisition. PACd ata can be affected by various equipment-related factors. One of the most common measurement errors results from incorrect leveling of the pressuret ransducer (33) . Most modern monitors perform automated calibration. Dynamic "tuning" ensures that the system is responsive to small pressurechanges. This depends on ac ontinuous non-compressible column of fluid contained within noncompliant pressuretubing. Signal loss/dampening can result from intracatheter air bubbles, debris, loose connections, vessel wall impingement, and transducer malfunction. Before placement, as imple qualitative test of catheter responsiveness is performed by flicking the catheter tip, which should produce ab risk high-frequency response within the waveform. After placement, a rapid flush test will clear the tubing and confirm responsiveness. In awell-responsive system, the pres-In awell-responsive system, the pressuretracing shows an initial horizontal straight line with as harp high-pressurer eading. Upon stopping the flush, the pressured rops immediately and returns to the horizontal baseline with ab rief, welldefined oscillation.
At hermistor at the catheter tip allows measurement of CO by thermodilution technique. Potential sources of error include timing, duration, volume and temperatureo ft he injectate used. These errors have become less common with use of continuous cardiac output (CCO) devices. Malposition of the catheter (i.e., lodging in the RV)o rd isplaced injectate port into the RA due to the patient's small statureshould be considered when hemodynamic measurements are inconsistent with the overall clinical picture. In addition, misconnection of pressuremonitors, wherethe distal PA and CVP trace can be potentially confused, making pressurew aveform determination impossible.
Continuous or intermittent sampling of mixed venous blood from the distal lumen of the catheter (properly positioned in the PA)allows determination of mixed venous oxygen saturation (SvO 2 ), calculation of various metabolic indices, and provides an indirect measureo ft he adequacy of tissue oxygen delivery.F actors affecting the interpretation of SvO 2 data include anemia, hemoglobin abnormalities, and abnormally high oxygen consumption, which can produce apattern consistent with low CO. Extracardiac arterio-venous shunting (i.e., sepsis) or metabolic blockade of electron transport (i.e., cyanide poisoning) may cause poor oxygen uptake and utilization in the tissue beds not related to the adequacy of oxygen delivery (2) .
Factors affecting PA C-derived data interpretation. When the PACtip is positioned properly and the balloon is inflated, the PA pressuret racing disappears due to PA blood flow occlusion. The resulting non-
The resulting nonpulsatile pressuret racing is called the Pulmonary Capillary Wedge/Occlusion Pressure(PCWP/PAOP). PCWP is ar eflection of Left Atrial (LA) pressure, which, in the absence of mitral valve disease, is asurrogate of LV diastolic pressure/cardiac preload. Mechanical ventilation can influence PA pressured ata, and in these patients, PA pressurem easurements should be obtained at end-exhalation when intrathoracic pressureisclosest to neutral. Positive end-expiratory pressure( PEEP) transmits pressurei nto the vascular space, confounding PA and PCWP measurements. In these cases, following trends rather than absolute values in PCWP or PA pressures or alternatively end-diastolic volume index (EDVI) or stroke index (SI) techniques may be moreu seful. In addition, certain modes of mechanical ventilation such as high frequency oscillation (HFOV), may make PCWP measurements unreliable (34) (35) .
In the absence of heart or lung disease, central venous pressure( CVP) and right atrial pressurea pproximate the RV end diastolic pressure(0-5 mmHg), andfluctuatewithintrathoracic respiratory variation.
These pressures areinfluenced by the patient's intravascular volume status (36) . Common causes of elevated CVP include biventricular heart failure, tricuspid regurgitation/stenosis, pulmonary hypertension, intravascular volume overload, constrictive pericarditis, and cardiactamponade. Pulmonaryarterysystolic pressuremay be elevated in certain high-flow states, volume overload, left ventricular failure, and highresistance states (i.e., acute/chronic pulmonary hypertension, mitral valve disease) (34) (35) . High volume infusion devices connected to the side port of the PACi ntroducer may also influence pressurebased measurements. For amorecomplete discussion of these issues, the reader is referred to other sources (5, (34) (35) (37) (38) .
Direct calculation of hemodynamic parameters by modern devices has essentially eliminated mathematical errors. However,t he accuracy of hemodynamic parameters is dependent upon the input data. The input of actual as opposed to ideal body weight in obese patients, for example, may significantly change indexed hemodynamic values obtained and thus affect therapeutic decisions based on these values (35, (37) (38) (39) .
One of the most common "beginner" mistakes is targeting asingle parameter derived from the PACto the exclusion of other endpoints. An individualized approach to each patient's hemodynamics and careful consideration of all clinical variables may be the best approach to maximizing the usefulness of PACderived data (1) . The subsequent sections of this manuscript will discuss some of the selected PACrelated complications in mored etail, focusing on their identification and management.
PULMONARYARTERYRUPTURE
The most feared, but thankfully avoidable complication of PACplacement and use is PA rupture (7) . For-Fortunately this complication is rare(incidence of 0.03%-0.20%) (7) (8) . In areview of 32,442 patients requiring PACs, therew ere1 0e pisodes of PA rupture ( 7) . All 10 patients had hemoptysis and 70% died (7) . Shah et al reported 4c ases of PA rupturea mong 6,245 PAC insertions (8) . Proposed risk factors for PAC-associated PA rupturei nclude age >60 years, pulmonary hypertension, improper balloon inflation, improper catheter positioning, cardiopulmonary bypass, and anticoagulation (7) .
Inflation of the PACb alloon should never require force, and the balloon should not be overinflated. Another warning sign includes the occurrence of "overwedging". If a"wedged" waveform is achieved without full balloon inflation, then the catheter should be withdrawn until an ormal PA wave-form is observed. Patients with pulmonary hypertension area tp articular risk for PA rupture, and consideration should be given to use of newer end-diastolic volume index (EDVI) catheters or following PA diastolic pressures in lieu of PCWP in these patients. Some even propose that use of EDVI catheters might obviate the need for wedge pressures thereby minimizing risk.
Perforation/ruptureofthe PA areusually heralded by new onset hemoptysis (7, 26) , and includes intubation, making ruptured side (if known) dependent, and high levels of PEEP.The presence of hemothorax associated with PA rupturemandates immediate thoracotomy and surgical repair (7, 40) . Management of ongoing endobronchial hemorrhage is difficult, and can include both non-surgical (single lung isolation) and/or surgical approaches (7, 41) .
PACKNOTTING
PACknotting is an uncommon but serious complication. PACs arem orel ikely to knot than other intravascular catheters because of their length and thin flexible walls increasing their propensity to coil (Fig.  2) (41) . The incidence of PACknotting is estimated to be 0.03% of all PACp lacements (41) (42) (43) . Of these, PACs account fora bout two-thirds of the cases (42) (43) . PACk notting is usually associated with inserting the catheter too far in patients prone to have coiling in the right ventricle. Diagnosis is confirmed radiographically.
When advancing/inserting aP AC, one must always correlate the intravascular length of the catheter in context of the right ventricular (RV) waveform (42) . Knotting can be prevented by carefully monitoring the transduced waveform and correlating it to the expectedw aveforma ts pecific catheteri nsertion depths (42) . If RV waveform pattern is still present 20 cm after its initial appearance, or at an absolute distance of 60 cm catheter coiling is likely (Fig. 3C) . At this point, the catheter should be slowly withdrawn to reduce the risk of knotting (42) . If thereisrepeated difficulty passing through the RV with the PAC, changing patient positioning may solve the problem, but fluoroscopic guidance is occasionally required.
Interventional endovascular techniques have been described to unknot catheters with avariety of wires, snares, and balloon catheters tailored for specific circumstances (42) (43) (44) (45) . For knots that arenot amenable to endovascular techniques, large multi-loop knots, or knots with ab ow-tie configuration, open extraction via venotomy may be needed (42) (43) . In one report, surgical removal was necessary in 37% of knotting cases, with 11%overall mortality due to PAC knotting (44) .
BALLOON FAILURE AND BREAKING OF THE PAC
With repeated inflation, cracks within the PACb alloon can occur resulting in up to 17% balloon rupture rate in early PACseries (5) . Shearing and intravascu-Shearing and intravascular retention of the balloon during PACr emoval through the introducer has also been described (46) . Passage through as ize mismatched introducer as well as repeated PACre-insertions can also cause balloon damage. An unusual cause of PACballoon rupturemay occur during anesthesia with nitrous oxide (N 2 O) due to increased solubility of this gas. N 2 Odiffuses into the balloon and increases its diameter,po-tentially causing difficulties when floating and/or manipulating the PAC (47) . While structural failures of PA catheters arer are( incidence~0.4%) (16) , PAC fragments can undergo remote embolization, including thepulmonary artery (48) .
PACDISLODGEMENT,MIGRATION, AND WEDGING IN DISTAL VA SCULATURE
Need for PA catheterization should be evaluated at least daily and catheters removed when no longer needed (1) . Chest radiograms areu sed to monitor PACp ositioning (Fig. 3A-D) , and catheters should not be advanced >5 cm beyond the midline. Pulmonary infarction can result from distal PACmigration and obstruction of the PA by the catheter (Fig. 3B) . PACmisplacement into the distal vasculatureisrare, but cases of placement into the brachiocephalic vein with perforation have been described (49, 50) . Misplacement of the PACcan also occur in patients with septal defects. Left carotid advancement of aP AC after VSD repair has been described (51), and others have described PACpassage via ASD from SVC into the left atrium and aorta (52) . During cardiac surgical procedures, PACs can become inadvertently trapped by sutures or staples, most commonly at the site of vena cava cannulation/atriotomy (53) . Intrahepatic wedging of the catheter may also occur (Fig. 3D ). It is imperative to frequently re-examine PACpositioning and to be vigilant for catheter malpositioning or potential entanglement with other intravascular objects/devices.
ARTERIAL INSERTION/PASSAGE OF THE PAC
Arterial placement of the PACismost commonly due to arterial placement of the introducer sheath ( Fig. 1) . Aortic misplacement of the PAChas been previously described (54) . Arterial placement of the PACi su nusual but may not be readily recognized in patients with profound hypotension during placement. If arterial placement of the introducer is not identified, the waveform during PACfl otation is pathognomonic. Incorrect positioning of the PACb alloon should be identifiable either based on perceived anatomic anomaly or the lack of an appropriate waveform. Right carotid placement of aP AC after VSD repair has also been reported (51). Radiographic confirmation is sometimes required to confirm arterial placement.
VENOUS THROMBOSIS
Thrombosis is common following CV access procedures, and results from endothelial disruption, and interruption of laminar blood flow.C atheter-related thromboses can occur with any catheter type and incidence varies with site of insertion. Subclavian ve-Subclavian venous catheterization carries the lowest thrombotic risk (1.9%), followed by internal jugular (7.6%) and femoral catheter placement (22%) (11) (12) (13) .
Electron microscopystudiesofP AC-related thrombosis noted platelet aggregation/thrombus formation as early as 24 hours post-insertion, with moredrastic increases at >72 hours. Balloon cracks can become an additional nidus for thrombosis (27) . Pro-thrombotic endothelial damage also occurs with PACb alloon inflation. In an autopsy study of 36 patients with PACs, 61% had mural thrombosis in the superior vena cava, the right atrium, or the PA.T he same study also noted that 11%had evidence of pulmonary infarction (28) . The incidence of life-threatening pul-
The incidence of life-threatening pulmonary embolism does not appear to be elevated in patients having PACs and the risk of thrombosis is may be reduced by minimizing duration of PAC.
COMPLICATIONS OF HEPARIN COATED CATHETERS
In an attempt to minimize thrombotic complications, heparin bonded catheters werei ntroduced in the early 1980's and indeed reduced catheter associated thrombotic events (55) . Following theirintroduction, reports appeared of heparin coated catheters initiating/prolonging episodes of Heparin induced thrombocytopenia (HIT). HITisanimmune-mediatedphenomenon associated with heparin infusion doses as low as 3u nits/hr (42) . Laster et al confirmed these reports by showing that heparin coated catheters placed in patients with heparina ntibodies cause platelet aggregation (56) . The most important therapy for HIT requires removal of all sources of exogenous heparin, including indwelling catheters and keeping the patient heparin-free for life (42) .
INFUSION SYNDROMES
Extravasation of medically active compounds into surrounding tissue can have significant clinical consequences. PACs ares eldom culprits for extravasation because their ports arel ocated far downstream from the insertion site. In contrast, PACi ntroducer sheathsa re associated with extravasatione pisodes because of their morep roximal ports and short length. Some causes of extravasation include retrograde flow due to afibrin sheath formation/catheter obstruction, adefect in the catheter,dislodgement or accidental withdrawal of the catheter and erosion of the catheter tip through av essel wall (57) . Body habitus may contribute to introducer extravasations (42) . Symptoms of introducer extravasation in ICU patients can include local tissue injury,b ut also lack of therapeutic benefit (i.e., patient effectively not receiving vasopressor and/or inotropic agents).
Extravasation is of greatest concern with chemotherapeutic drugs, vasopressors, potassium chloride, calcium, vancomycin, and promethazine, all of which may contribute to skin reactions and/or necrosis (58) . Compartment syndrome is also possible following large volume infusions into soft tissues of extremities. If suspected, radiographic confirmation of catheter placement is mandatory in all non-emergent situations. Also, prior to any infusion via ag iven port, theres hould be easy flow in all directions (42, 57) .
PACENTANGLEMENT WITH OTHER INTRAVA SCULAR DEVICES
It is well documented that the PACc an become entangled with an IVC filter,n ecessitating surgical removal of the PACafter failed percutaneous attempts (9) . Fluoroscopic guidance for positioning of PACin patients with similar high-risk intravascular devices should be considered, especially when difficult placement is anticipated. It may be possible to reduce the incidence of mechanical complications by maintaining the intravascular PACi nsertion distance to less than 60 cm in the absence of RV waveform.
OTHER PAC-RELATED COMPLICATIONS
Otherreportedcomplicationsofindwelling PACs include retrograde coronary sinus perfusion, cannulation of the intrathecal space and hepatic vein wedging and obstruction (Figure3 D), among others (59) (60) . It is important to note that hepatic venous placement of the PACtends to occur moreoften following femoral venous PACplacement.
ALTERNATIVES TO PULMONARYARTERY CATHETERS
Many alternatives to the PACh ave been developed, including esophageal Doppler monitoring (EDM), bedside echocardiography,arterial waveform analysis, transpulmonary thermodilution, and impedance cardiography (61) (62) .
Esophageal Doppler monitoring (EDM) -m easures blood flow velocity in the descending thoracic aorta using aflexible probe housing aDoppler transducer. These esophageal probes areplaced at the mid-chest level directed towardt he descending aorta (62) (63) . EDM combines Doppler estimates of aortic blood flow and cross-sectional area for real-time estimation of CO (62) (63) . EDM has been shown to have acceptable measurement bias for CO monitoring when compared to PAC/thermodilution, and EDM monitoring has afavorable safety profile (63) (64) (65) (66) (67) . Disadvantages of EDM include need for frequent positional readjustments, patient discomfort, and the steep user learning curve (62) (63) 66) . Recent studies, while noting the limitations of EDM, support its use in the critical care setting (62, 66) . In inert gas rebreathing,p atients rebreathe from ac ontainer filled with oxygen mixed with other gases (typically nitrous oxide and sulphur hexafluoride). The blood-soluble nitrous oxide is ab-
The blood-soluble nitrous oxide is absorbed during the blood's passagethrough the lungs at ar ate that is proportional to the blood flow.T he sulphur hexafluoride is insoluble in blood and thereforestays in the gaseous phase and is used to determine the lung volume from which the soluble gas is removed. These gases and CO 2 arem easured continuously and simultaneously (64, 68) . Cardiac output can also be estimated by using the partial CO 2 rebreathing technique, which employs the Fick principle (with CO 2 as the marker gas) (61) . In transpulmonary thermodilution,acold saline bolus is injected into the central venous (CV) circulation and temperature change across the cardiopulmonary system is measured via CV catheter.T ranspulmonary thermodilution requires invasive CV catheter and athermistortipped femoral artery catheter.Anadvantage of this technique is its ability to estimate extravascular lung water in patients with pulmonary edema (61) . Thoracic electrical bioimpedance (TEB)allows non-invasive determination of CO, stroke volume (SV), systemic vascular resistance (SVR), cardiac contractility,a nd thoracic fluid content (TFC) (61, 64) . Therea re close correlations between CO measurements of TEB, thermodilution, and the Fick method (64, 69) . TEB shows some promise in short-term management of acutely ill hospitalized patients, but further clinical studies aren eeded (70) (71) . Tr ans-thoracic echocardiography (TTE)p rovides an on-invasive alternative to hemodynamic monitoring.Intensivist bedside ultrasonography featuring both echocardiography and vena cava measurements can be used to determine patient intravascular volume status and cardiac performance (36) . Limitations include operator experience, noncontinuous (although repeatable) measurements, and patient factors impeding cardiac visualization (obesity,surgicaldressings, etc) (36, 72) .T rans-esophageal echocariography (TEE) is morea ccurate than TTE, but is moreinvasive, limited to expert operators, and may requirepatient sedation (10) . Despite these lim-Despite these limitations, echocardiography can provide dynamic information not available with PAC( i.e., analysis of regional myocardial wall motion and valvular function) (36) . Arterial pulse contour analysis correlates arterial pulse contours with stroke volume to estimate CO (73) . Several commercial systems area vailable, operating either in calibrated (i.e., with lithium dilution method) or non-calibrated (i.e., without calibrating bolus) fashion. This method is generally accurate (74)a nd requires only the presence of arterial line. Thereare also stand alone devices to determine central venous oxygen saturation (SCvO 2 )aswell as tissue oxygenation (StO 2 ). In case of SCvO 2 catheters, this numeric value can approximate the value of SvO 2 .T issue oxygenation monitors provide the practitioner with real-time information regarding perfusion at the tissue level, which may be useful when treating patients in various types of shock.
CONCLUSIONS
Pulmonary artery catheters provide clinicians with wealth of potentially useful hemodynamic information. If this information is used correctly,i tm ay be very helpful in patient management. However,placement and use of the PACm ay be associated with a variety of complications. Not only must every prac-Not only must every practitionerwho uses the PACbefamiliarwith aspectsof its placement and long-term maintenance, but they must also be knowledgeable in interpretation and use of theh emodynamic information providedb yt he catheter.C onsequently,p roper use of the PACd e-roper use of the PACd epends upon athorough understanding of factors contributing to measurement errors and data misinterpretation. Inappropriate clinical decisions and/or inaccurate hemodynamic data may well constitute a greater risk to the patient than all the other PAC-related complications (1, 5, 37) .
